{"id":40888,"date":"2023-06-05T10:55:42","date_gmt":"2023-06-05T08:55:42","guid":{"rendered":"http:\/\/osaraba.eus\/infoberriak\/?p=40888"},"modified":"2023-06-05T10:55:42","modified_gmt":"2023-06-05T08:55:42","slug":"aztertuko-den-medikamentu-berria-romosozumab","status":"publish","type":"post","link":"https:\/\/osaraba.eus\/infoberriak\/eu\/aztertuko-den-medikamentu-berria-romosozumab\/","title":{"rendered":"Aztertuko den Medikamentu Berria: Romosozumab"},"content":{"rendered":"<h4><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-40893 size-full\" src=\"https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?resize=775%2C367\" alt=\"\" width=\"775\" height=\"367\" srcset=\"https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?w=775&amp;ssl=1 775w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?resize=300%2C142&amp;ssl=1 300w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?resize=768%2C364&amp;ssl=1 768w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?resize=520%2C245&amp;ssl=1 520w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?resize=720%2C340&amp;ssl=1 720w\" sizes=\"auto, (max-width: 775px) 100vw, 775px\" \/><\/h4>\n<h4 style=\"text-align: center;\">\u00ab<strong>Aztertuko den Medikamentu Berria<\/strong>\u00bb izeneko fitxaren helburua hauxe da: Estatuan merkaturatzen diren medikamentu berriei buruz informazio objektiboa, ebaluatua, independientea eta zehatza eskaintzea<\/h4>\n<p style=\"text-align: justify;\">Romosozumab osteoporosi larria tratatzeko, menopausia osteko aldian dauden emakumeekin erabiltzeko, hausturak izateko arrisku handia dutenean<b>\u00a0<\/b>\u00abAztertuko den Medikamentu Berria\u00bb izeneko fitxa eskuragarri dago\u00a0<a title=\"https:\/\/www.euskadi.eus\/informazioa\/lehen-mailako-atentzioko-medikamendu-berrien-ebaluazioa\/web01-a2cevime\/eu\/\" href=\"https:\/\/www.euskadi.eus\/informazioa\/lehen-mailako-atentzioko-medikamendu-berrien-ebaluazioa\/web01-a2cevime\/eu\/\" target=\"_blank\" rel=\"noopener\" data-cke-saved-href=\"https:\/\/www.euskadi.eus\/informazioa\/lehen-mailako-atentzioko-medikamendu-berrien-ebaluazioa\/web01-a2cevime\/eu\/\" data-interception=\"off\">web-orrian<\/a>,\u00a0<b>Medikamentu Berrien Ebaluazioko Euskadiko Batzordeak<\/b>\u00a0egindakoak.<\/p>\n<p style=\"text-align: justify;\">Ebaluazioak, Euskadiko Medikamentu Berrien Ebaluazio-batzordeak (MBEBek) egiten ditu. Batzorde horretan, Osasun Saileko, Osakidetzako eta Euskal Herriko Unibertsiteteko profesional sanitarioak sartuta daudelarik.<\/p>\n<p><a title=\"https:\/\/www.euskadi.eus\/contenidos\/informacion\/medicamentos_atencion_primaria\/eu_def\/adjuntos\/EUSKERA.pdf\" href=\"https:\/\/www.euskadi.eus\/contenidos\/informacion\/medicamentos_atencion_primaria\/eu_def\/adjuntos\/EUSKERA.pdf\" target=\"_blank\" rel=\"noopener\" data-interception=\"off\" data-cke-saved-href=\"https:\/\/www.euskadi.eus\/contenidos\/informacion\/medicamentos_atencion_primaria\/eu_def\/adjuntos\/EUSKERA.pdf\">Fitxa<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00abAztertuko den Medikamentu Berria\u00bb izeneko fitxaren helburua hauxe da: Estatuan merkaturatzen diren medikamentu berriei buruz informazio objektiboa, ebaluatua, independientea eta zehatza eskaintzea.<\/p>\n","protected":false},"author":6,"featured_media":40893,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[956],"tags":[1048],"class_list":["post-40888","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-portadan","tag-farmazia-eu"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/miez.jpg?fit=775%2C367&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/paCxCe-aDu","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/posts\/40888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/comments?post=40888"}],"version-history":[{"count":0,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/posts\/40888\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/media\/40893"}],"wp:attachment":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/media?parent=40888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/categories?post=40888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/tags?post=40888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}